TY - JOUR
T1 - Structural biology of carbohydrate xenoantigens
AU - Yuriev, Elizabeth
AU - Agostino, Mark James
AU - Farrugia, W
AU - Christiansen, Dale
AU - Sandrin, Mauro Sergio
AU - Ramsland, Paul Allen
PY - 2009
Y1 - 2009
N2 - Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.
AB - Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.
UR - http://informahealthcare.com/doi/abs/10.1517/14712590903066703
U2 - 10.1517/14712590903066703
DO - 10.1517/14712590903066703
M3 - Article
SN - 1471-2598
VL - 9
SP - 1017
EP - 1029
JO - Expert Opinion on Biological Therapy
JF - Expert Opinion on Biological Therapy
IS - 8
ER -